Stem price target raised to $13 from $7 at Roth Capital

Roth Capital raised the firm’s price target on Stem (STEM) to $13 from $7 and keeps a Neutral rating on the shares. The company delivered an across-the-board Q2 beat as growth of high-margin software revenue exceeded expectations, the analyst tells investors in a research note. Stem management also reiterated 2025 guidance indicating they are tracking toward the high end of all metrics, the firm added.